Ener1 Names Wilson Greatbatch to Advisory Committee

Inventor of Pacemaker With Strong Ties to Medical Device Industry

to Assist Lithium Battery Company

Sep 08, 2004, 01:00 ET from Ener1, Inc.

    FORT LAUDERDALE, Fla., Sept. 8 /PRNewswire-FirstCall/ -- Ener1, Inc.
 (OTC Bulletin Board:   ENEI), an emerging leader in the development of advanced
 lithium batteries, fuel cells and nanotechnology, has named Mr. Wilson
 Greatbatch to the company's independent Advisory Committee. Mr. Greatbatch
 invented the first successful implantable cardiac pacemaker and the lithium
 battery technology that is considered today's international standard for
 pacemakers and implantable cardioverter defibrillators.
     "It is a true honor to have one of America's greatest inventors and
 entrepreneurs join our company as a strategic advisor," said Kevin Fitzgerald,
 Chairman and Chief Executive Officer of Ener1, Inc.  "His inventions have
 greatly enhanced the quality of life for millions of patients around the
 world. Ener1 should benefit from his insights and relationships in the medical
 device industry, a market where we see great potential for our battery
     Ener1 is pursuing product opportunities for its high-rate lithium
 batteries in the medical device market, such as pacemakers and defibrillators.
 The market for these cardiac rhythm management devices is estimated at more
 than $5 billion dollars, with the defibrillator share growing at an estimated
 15 to 25 percent annually.  Ener1 believes its lithium battery technologies
 are well suited for cardiac devices that require safe, highly reliable, long-
 life power sources with fast charge capabilities. In addition to medical,
 other markets for the company's lithium batteries include power tools,
 industrial equipment, military and automotive.
     Mr. Greatbatch has more than 300 U.S. and International patents to his
 credit.  He currently serves as Chief Executive Officer of Greatbatch
 Enterprises Corporation, a research and development company he founded to
 design and develop components and devices for the medical device industry, as
 well as electrical energy for future generations.  He has received awards from
 the National Academy of Engineering, MIT (Lifetime Achievement Award) and many
 other prestigious institutions.
     Mr. Greatbatch noted, "I look forward to actively contributing to Ener1's
 efforts to establish itself in medical device and other markets.  My knowledge
 and experience in the medical device industry, together with Ener1's
 technologies, such as its high-rate battery and nanotechnology-based vapor
 deposition system, should be an excellent combination for pursuing the growing
 opportunities in those markets."
     About Ener1, Inc.
     Ener1, Inc. (OTC Bulletin Board:   ENEI) develops and markets new
 technologies and products for clean, efficient energy sources, including fuel
 cell systems and components, high-energy lithium batteries and components, and
 nanotechnology-based materials and manufacturing processes. Ener1's
 technologies and products have applications for industrial, medical, consumer
 and military markets. Potential applications include power tools and
 industrial equipment, medical devices, hybrid vehicle propulsion and military
 communications. For more information on Ener1's technologies and products,
 visit its Web site at http://www.ener1.com .
     Safe Harbor Statement
     This release contains forward-looking statements within the meaning of the
 Federal Private Securities Litigation Reform Act of 1995 conveying
 management's expectations as to the future based on plans, estimates and
 projections at the time the statements are made. The forward-looking
 statements contained in this press release involve risks and uncertainties,
 including, but not necessarily limited to, Ener1's ability to successfully
 develop and market its proposed products and services, the degree of
 competition in the market for Ener1's products and services, Ener1's history
 of operating losses, the lack of any operating history for Ener1's development
 stage battery and fuel cell business, the potential need for additional
 capital and Ener1's dependency upon key personnel. These and other risks are
 detailed in Ener1's annual report on Form 10-KSB for the year ended December
 31, 2003, as well as in its other filings from time to time with the
 Securities and Exchange Commission. These risks and uncertainties could cause
 actual results or performance to differ materially from any future results or
 performance expressed or implied in the forward-looking statements included in
 this release. Ener1 undertakes no obligation to publicly update or revise any
 forward-looking statements, whether as a result of new information, future
 events, or otherwise.
      Media Contact:
      Alys Daly
      954-556-4020 or

SOURCE Ener1, Inc.